U.S. flag

An official website of the United States government

NM_002667.5(PLN):c.85C>T (p.Gln29Ter) AND Dilated cardiomyopathy 1P

Germline classification:
Pathogenic (1 submission)
Last evaluated:
Dec 24, 2023
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV001221395.6

Allele description [Variation Report for NM_002667.5(PLN):c.85C>T (p.Gln29Ter)]

NM_002667.5(PLN):c.85C>T (p.Gln29Ter)

Genes:
CEP85L:centrosomal protein 85 like [Gene - OMIM - HGNC]
PLN:phospholamban [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
6q22.31
Genomic location:
Preferred name:
NM_002667.5(PLN):c.85C>T (p.Gln29Ter)
HGVS:
  • NC_000006.12:g.118559006C>T
  • NG_009082.1:g.15728C>T
  • NG_021248.1:g.156070G>A
  • NM_001042475.3:c.1020+6523G>AMANE SELECT
  • NM_001178035.2:c.1029+6523G>A
  • NM_002667.5:c.85C>TMANE SELECT
  • NM_206921.3:c.1020+6523G>A
  • NP_002658.1:p.Gln29Ter
  • LRG_390t1:c.85C>T
  • LRG_390:g.15728C>T
  • NC_000006.11:g.118880169C>T
  • NM_002667.3:c.85C>T
Protein change:
Q29*
Links:
dbSNP: rs1779072006
NCBI 1000 Genomes Browser:
rs1779072006
Molecular consequence:
  • NM_001042475.3:c.1020+6523G>A - intron variant - [Sequence Ontology: SO:0001627]
  • NM_001178035.2:c.1029+6523G>A - intron variant - [Sequence Ontology: SO:0001627]
  • NM_206921.3:c.1020+6523G>A - intron variant - [Sequence Ontology: SO:0001627]
  • NM_002667.5:c.85C>T - nonsense - [Sequence Ontology: SO:0001587]

Condition(s)

Name:
Dilated cardiomyopathy 1P (CMD1P)
Identifiers:
MONDO: MONDO:0012362; MedGen: C1835928; Orphanet: 154; OMIM: 609909

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV001393436Invitae
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Pathogenic
(Dec 24, 2023)
germlineclinical testing

PubMed (7)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Human phospholamban null results in lethal dilated cardiomyopathy revealing a critical difference between mouse and human.

Haghighi K, Kolokathis F, Pater L, Lynch RA, Asahi M, Gramolini AO, Fan GC, Tsiapras D, Hahn HS, Adamopoulos S, Liggett SB, Dorn GW 2nd, MacLennan DH, Kremastinos DT, Kranias EG.

J Clin Invest. 2003 Mar;111(6):869-76.

PubMed [citation]
PMID:
12639993
PMCID:
PMC153772

Genetic screening of calcium regulation genes in familial hypertrophic cardiomyopathy.

Chiu C, Tebo M, Ingles J, Yeates L, Arthur JW, Lind JM, Semsarian C.

J Mol Cell Cardiol. 2007 Sep;43(3):337-43. Epub 2007 Jun 30.

PubMed [citation]
PMID:
17655857
See all PubMed Citations (7)

Details of each submission

From Invitae, SCV001393436.5

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (7)

Description

This sequence change creates a premature translational stop signal (p.Gln29*) in the PLN gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 24 amino acid(s) of the PLN protein. This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with PLN-related conditions. ClinVar contains an entry for this variant (Variation ID: 949832). This variant disrupts a region of the PLN protein in which other variant(s) (p.Leu39*) have been determined to be pathogenic (PMID: 12639993, 17655857, 21167350, 25611685, 26535225, 27532257). This suggests that this is a clinically significant region of the protein, and that variants that disrupt it are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: May 1, 2024